| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 20,592 | 19,825 | 11,187 | | Cost of Revenue | 2,304 | 1,600 | 1,401 | | | Gross Profit | 18,288 | 18,225 | 9,786 | | | Operating Expenses | | Research Development | 2,907 | 3,498 | 2,360 | | Selling General and Administrative | 12,494 | 12,002 | 8,314 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,887 | 2,725 | (888) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (124) | 130 | 136 | | Earnings Before Interest And Taxes | 2,763 | 2,855 | (752) | | Interest Expense | 194 | 900 | 527 | | Income Before Tax | 2,569 | 1,955 | (1,279) | | Income Tax Expense | 179 | 324 | 82 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,390 | 1,631 | (1,361) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (1,445) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,390 | 1,631 | (2,806) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,390 | $1,631 | ($2,806) |
|
0.03% Nasdaq 0.00%
Income Statement
